BioCorRx annual return on equity
2011
2012
2013
2014
BioCorRx Return on Equity (ROE) Growth & History (BICX)
BioCorRx's return on equity was −1,182.31% for fiscal 2014.
View full BioCorRx company overviewBioCorRx annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2014 | 2014-12-31 | −1,182.31% | −931.41 pp |
| 2013 | 2013-12-31 | −250.91% | −222.90 pp |
| 2012 | 2012-12-31 | −28.00% | −3.34 pp |
| 2011 | 2011-12-31 | −24.66% | — |
BioCorRx quarterly return on equity
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q3.14
Q4.14
Q1.15
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2015 | 2015-03-31 | −88.84% | — |
| Q4 2014 | 2014-12-31 | −483.79% | −257.61 pp |
| Q3 2014 | 2014-09-30 | −100.41% | −95.93 pp |
| Q4 2013 | 2013-12-31 | −226.18% | −216.95 pp |
| Q3 2013 | 2013-09-30 | −4.48% | +0.78 pp |
| Q2 2013 | 2013-06-30 | −5.30% | +7.91 pp |
| Q1 2013 | 2013-03-31 | −1.88% | −1.34 pp |
| Q4 2012 | 2012-12-31 | −9.23% | −0.84 pp |
| Q3 2012 | 2012-09-30 | −5.26% | −8.30 pp |
| Q2 2012 | 2012-06-30 | −13.21% | −11.50 pp |
| Q1 2012 | 2012-03-31 | −0.54% | — |
| Q4 2011 | 2011-12-31 | −8.38% | — |
| Q3 2011 | 2011-09-30 | 3.04% | — |
| Q2 2011 | 2011-06-30 | −1.71% | — |
BioCorRx return on equity trends
Between the periods ended 2011-12-31 and 2014-12-31, BioCorRx's return on equity decreased from −24.66% to −1,182.31%, a change of −1157.65 percentage points. The latest reported quarter, Q1 2015, shows −88.84%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioCorRx source filings ↗